Advertisement

APA Calls for Less Antipsychotic Use — Physician’s First Watch

Medical News |
September 23, 2013

APA Calls for Less Antipsychotic Use

By Amy Orciari Herman

In concert with the American Board of Internal Medicine's "Choosing Wisely" initiative, the American Psychiatric Association has released its list of "Five Things Physicians and Patients Should Question." The list, focusing on limiting antipsychotic use, advises the following:

  • Don't prescribe antipsychotics without "appropriate" evaluation and continual monitoring.

  • Don't routinely prescribe two or more antipsychotics at the same time.

  • Don't prescribe antipsychotics as first-line treatment for the behavioral or psychologic symptoms of dementia.

  • Don't routinely use antipsychotics as first-line therapy for insomnia.

  • Don't routinely prescribe antipsychotics as first-line treatment for pediatric patients for any condition other than a psychotic disorder.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement